These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1494234)

  • 21. [Clinical study on cefprozil in pediatrics].
    Iwai N; Miyazu M; Nakamura H; Kasai K
    Jpn J Antibiot; 1992 Nov; 45(11):1537-57. PubMed ID: 1494236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics and clinical effects of cefdinir 5% fine granules in pediatrics].
    Motohiro T; Handa S; Yamada S; Oki S; Tsumura N; Yoshinaga Y; Aramaki M; Shimada Y; Kawakami A; Koga T
    Jpn J Antibiot; 1990 Oct; 43(10):1813-35. PubMed ID: 2086819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Laboratory and clinical studies of cefdinir 5% and 10% fine granules in pediatric field].
    Nishimura T; Tabuki K; Aoki S; Takagi M
    Jpn J Antibiot; 1991 Oct; 44(10):1142-57. PubMed ID: 1762170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field. Pediatric Study Group of ME1207].
    Fujii R; Yoshioka H; Okuno A; Fujita K; Murono K; Maruyama S; Sakata H; Iseki K; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1993 Jan; 46(1):95-114. PubMed ID: 8455336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies on cefprozil granules].
    Haruta T; Tsutsui T; Kuroki S; Okura K; Kobayashi Y
    Jpn J Antibiot; 1992 Dec; 45(12):1642-9. PubMed ID: 1289582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics and clinical effects of cefdinir 10% fine granules in pediatrics].
    Motohiro T; Handa S; Yamada S; Oki S; Tsumura N; Yoshinaga Y; Sasaki H; Aramaki M; Oda K; Kawakami A
    Jpn J Antibiot; 1992 Jan; 45(1):74-86. PubMed ID: 1495197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetic and clinical studies of S-1108 in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Sano T; Nakamura H
    Jpn J Antibiot; 1993 Nov; 46(11):991-1002. PubMed ID: 8309075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical evaluation of cefdinir 5% fine granules in pediatrics].
    Iwai N; Nakamura H; Taneda Y; Miyazu M; Kasai K; Watanabe Y
    Jpn J Antibiot; 1991 Oct; 44(10):1096-118. PubMed ID: 1762167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetic, bacteriological and clinical evaluation of cefditoren pivoxil in pediatrics].
    Iwai N; Nakamura H; Miyazu M; Watanabe Y
    Jpn J Antibiot; 1994 Feb; 47(2):181-94. PubMed ID: 8151911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical studies on S-1108 in the field pediatrics].
    Kuno K; Ogawa A; Hayakawa F; Ito K; Kondo M; Okumura A; Natsume J
    Jpn J Antibiot; 1993 Nov; 46(11):1017-24. PubMed ID: 8309064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetic, bacteriological and clinical studies on cefdinir fine granules in the field of pediatrics].
    Haruta T; Kuroki S; Okura K; Yoshida N; Kobayashi Y
    Jpn J Antibiot; 1991 Oct; 44(10):1158-67. PubMed ID: 1762171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies on cefteram pivoxil granules in pediatrics].
    Sato H; Narita A; Nakazawa S; Suzuki H; Matsumoto K; Nakanishi Y; Niino K; Nakazawa S
    Jpn J Antibiot; 1989 Sep; 42(9):1948-62. PubMed ID: 2810757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The influence of cefprozil on intestinal bacterial flora].
    Iwata S; Ikeda M; Yamada K; Isohata E; Kin Y; Kusumoto Y; Sato Y; Akita H; Nanri S; Oikawa T
    Jpn J Antibiot; 1992 Nov; 45(11):1474-88. PubMed ID: 1494231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies on SY5555 in pediatric infections].
    Niinou K; Sigeta M; Kuwahata K; Suzuki H; Sato H
    Jpn J Antibiot; 1995 Jan; 48(1):49-70. PubMed ID: 7699845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Laboratory and clinical studies on cefdinir (10% fine granules) in pediatric field].
    Kuno K; Ogawa A; Takeuchi H; Tomita K; Kitoh O; Andoh H; Takimoto Y
    Jpn J Antibiot; 1991 Oct; 44(10):1134-41. PubMed ID: 1762169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study on cefprozil fine granules].
    Ito M; Takeda E; Kuroda Y
    Jpn J Antibiot; 1992 Dec; 45(12):1663-6. PubMed ID: 1289585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Basic and clinical studies on S-1108 in pediatric field].
    Motohiro T; Handa S; Yamada S; Oki S; Yoshinaga Y; Aramaki M; Oda K; Sakata Y; Kato H; Yamashita F
    Jpn J Antibiot; 1993 Dec; 46(12):1122-44. PubMed ID: 8107277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1995 Jan; 48(1):71-91. PubMed ID: 7699846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetic and clinical studies of cefdinir in the pediatric field. Pediatric Study Group of Cefdinir].
    Fujii R; Yoshioka H; Fujita K; Sakata H; Nire H; Iseki K; Murono K; Takahashi Y; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1991 Oct; 44(10):1168-91. PubMed ID: 1762172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetic study on oral antibiotics in pediatrics. III. A pharmacokinetic study on cefprozil in pediatrics].
    Nakamura H; Iwai N
    Jpn J Antibiot; 1992 Nov; 45(11):1489-504. PubMed ID: 1494232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.